1. Home
  2. XRAY vs SUPN Comparison

XRAY vs SUPN Comparison

Compare XRAY & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XRAY
  • SUPN
  • Stock Information
  • Founded
  • XRAY 1899
  • SUPN 2005
  • Country
  • XRAY United States
  • SUPN United States
  • Employees
  • XRAY N/A
  • SUPN 674
  • Industry
  • XRAY Medical/Dental Instruments
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • XRAY Health Care
  • SUPN Health Care
  • Exchange
  • XRAY Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • XRAY 2.9B
  • SUPN 2.5B
  • IPO Year
  • XRAY 1987
  • SUPN 2012
  • Fundamental
  • Price
  • XRAY $14.62
  • SUPN $46.00
  • Analyst Decision
  • XRAY Hold
  • SUPN Buy
  • Analyst Count
  • XRAY 12
  • SUPN 2
  • Target Price
  • XRAY $19.10
  • SUPN $43.00
  • AVG Volume (30 Days)
  • XRAY 3.2M
  • SUPN 809.3K
  • Earning Date
  • XRAY 08-07-2025
  • SUPN 11-03-2025
  • Dividend Yield
  • XRAY 4.39%
  • SUPN N/A
  • EPS Growth
  • XRAY N/A
  • SUPN 1411.53
  • EPS
  • XRAY N/A
  • SUPN 1.14
  • Revenue
  • XRAY $3,671,000,000.00
  • SUPN $665,125,000.00
  • Revenue This Year
  • XRAY N/A
  • SUPN $4.84
  • Revenue Next Year
  • XRAY $2.31
  • SUPN $17.69
  • P/E Ratio
  • XRAY N/A
  • SUPN $40.09
  • Revenue Growth
  • XRAY N/A
  • SUPN 5.55
  • 52 Week Low
  • XRAY $12.16
  • SUPN $29.16
  • 52 Week High
  • XRAY $27.48
  • SUPN $46.08
  • Technical
  • Relative Strength Index (RSI)
  • XRAY 53.69
  • SUPN 73.94
  • Support Level
  • XRAY $13.66
  • SUPN $44.10
  • Resistance Level
  • XRAY $14.38
  • SUPN $45.94
  • Average True Range (ATR)
  • XRAY 0.39
  • SUPN 1.10
  • MACD
  • XRAY 0.11
  • SUPN -0.13
  • Stochastic Oscillator
  • XRAY 80.00
  • SUPN 97.91

About XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: